EFFECTIVENESS OF ABROCITINIB TREATMENT IN PATIENTS WITH DIFFICULT-TO-TREAT ATOPIC DERMATITIS: DAILY PRACTICE DATA

被引：0
|
作者：
Olydam, Jill [1 ]
Schlosser, Anne [1 ]
Custurone, Paolo [1 ]
Nijsten, Tamar [1 ]
Hijnen, Dirkjan [1 ]
机构：
[1] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P10.3
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] Abrocitinib for difficult-to-treat atopic dermatitis
    Lorenz, Judith
    [J]. AKTUELLE DERMATOLOGIE, 2023, 49 (12) : 546 - 546
  • [2] Real-world effectiveness of abrocitinib treatment in patients with difficult-to-treat atopic dermatitis
    Olydam, J. I.
    Schloesser, A. R.
    Custurone, P.
    Nijsten, T. E. C.
    Hijnen, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : 2537 - 2542
  • [3] Management of Difficult-to-Treat Atopic Dermatitis
    Arkwright, Peter D.
    Motala, Cassim
    Subramanian, Hamsa
    Spergel, Jonathan
    Schneider, Lynda C.
    Wollenberg, Andreas
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (02): : 142 - 151
  • [4] Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data
    de Wijs, L. E. M.
    Bosma, A. L.
    Erler, N. S.
    Hollestein, L. M.
    Gerbens, L. A. A.
    Middelkamp-Hup, M. A.
    Kunkeler, A. C. M.
    Nijsten, T. E. C.
    Spuls, P. I.
    Hijnen, D. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (02) : 418 - 426
  • [5] Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
    Eric L. Simpson
    Jonathan I. Silverberg
    Jacob P. Thyssen
    Manuelle Viguier
    Diamant Thaçi
    Marjolein de Bruin-Weller
    Stephan Weidinger
    Gary Chan
    Marco DiBonaventura
    Pinaki Biswas
    Claire Feeney
    Christopher Koulias
    Michael J. Cork
    [J]. American Journal of Clinical Dermatology, 2023, 24 : 609 - 621
  • [6] Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Viguier, Manuelle
    Thaci, Diamant
    de Bruin-Weller, Marjolein
    Weidinger, Stephan
    Chan, Gary
    DiBonaventura, Marco
    Biswas, Pinaki
    Feeney, Claire
    Koulias, Christopher
    Cork, Michael J.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (04) : 609 - 621
  • [7] Upadacitinib treatment in a real-world difficult-to-treat atopic dermatitis patient cohort
    Schloesser, Anne R.
    Boeijink, Neill
    Olydam, Jill
    Nijsten, Tamar E. C.
    Hijnen, Dirkjan
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : 384 - 392
  • [8] UPADACITINIB TREATMENT IN A REAL-WORLD DIFFICULT-TO-TREAT ATOPIC DERMATITIS PATIENT COHORT
    Schlosser, Anne Rosalie
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 29 - 29
  • [9] Abrocitinib for the treatment of atopic dermatitis
    Crowley, Erika L.
    Nezamololama, Novin
    Papp, Kim
    Gooderham, Melinda J.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (10) : 955 - 962
  • [10] Low serum vitamin D levels in adult patients with difficult to treat atopic dermatitis: recommendations for daily practice
    van der Schaft, J.
    Ariens, L. F. M.
    Hijnen, D.
    Bruijnzeel-Koomen, C. A. F. M.
    de Bruin-Weller, M. S.
    [J]. ALLERGY, 2015, 70 : 80 - 81
12345